# Phase 1b Influenza Vaccine Study in Healthy Subjects

> **NCT01181336** · PHASE1 · COMPLETED · sponsor: **PepTcell Limited** · enrollment: 48 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza vaccine (FLU-v)
- **BIOLOGICAL:** FLU-v Control

## Key facts

- **NCT ID:** NCT01181336
- **Lead sponsor:** PepTcell Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181336, "Phase 1b Influenza Vaccine Study in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01181336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*